VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies

Clinical trial NCT00070538 · COMPLETED

Trial details

NCT number: NCT00070538
Sponsor: Vion Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia Myelodysplastic Syndromes

Start date: 2003-06-01
Primary completion: 2004-09-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.